课题基金 / 基金详情

Invasion and Angiogenesis in Malignant Gliomas

Invasion and Angiogenesis in Malignant Gliomas
恶性胶质瘤的侵袭和血管生成
批准号:
7218651
负责人:
DAVID ZAGZAG
金额:
$26.28万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-02-28

项目摘要

项目成果

DAVID ZAGZAG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There is a dire need for novel therapy for brain tumors. Diffuse glioma cell invasion into surrounding brain tissue and angiogenesis are fundamental features of gliomas that have not been successfully addressed by conventional therapy to control tumor growth in brain tumor patients. Current aggressive local treatments such as surgery, radiotherapy and chemotherapy are effective at controlling the localized mass of tumor cells in the brain. This success is only temporary, because tumor cells that have already invaded into the surrounding brain and serve as seeds by which the tumor re-grows. The process by which these tumor cells invade into the brain is not well understood. New treatment approaches that are capable to control these invading tumor cells can have a dramatic impact on patient outcome. We have developed assays in vitro and in vivo that allow us to study invading glioma and endothelial cells. Our long-term goal remains to interfere with tumor invasion and angiogenesis to diminish tumor growth. To this end we propose i) to determine mechanisms involved in the migration of both endothelial and glioma cells; and ii) to investigate the mechanism and therapeutic potential of two geldanamycin analogues on glioma in vitro and in vivo. Our proposal seeks to take advantage of new molecular biologic techniques to improve our understanding of this process. Collectively, the proposed experiments will analyze the cellular and molecular pathways necessary for tumor invasion and angiogenesis. Results from these experiments will lead to future strategies designed to inhibit specific molecular components implicated in these critical processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification and molecular characterization of FGFR4 p.G388R variant signaling in cerebellar hemangioblastomas
Identification and molecular characterization of FGFR4 p.G388R variant signaling in cerebellar hemangioblastomas
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.
海外基金